Meet the
Precision AQ team
at the 2025 ASCO
Annual Meeting

100% of Precision AQ's Access Experience Team (AET) have managed oncology drugs for their former organization, including board certified oncology pharmacists and individuals with experience in key roles at leading US cancer organizations. Our team brings client partners the proactive expert insights they need to develop unique strategies and resources to tackle access challenges with unrivaled, real world, strategic insights.

By integrating comprehensive data analysis with real-world evidence, we craft strategies that address complex challenges and drive successful outcomes, ensuring that your products are well-prepared for market success. Our commitment to innovation and industry knowledge positions us to deliver transformative solutions that optimize your product's journey from concept to commercial success.

Precision AQ’s OncoGenius technology, which partners with 100+ leading cancer care organizations can be your competitive edge. We provide data-driven analyses of product placement on EHR treatment plans, clinical pathways, and formularies, so you can align your strategies with the real-world practices and preferences of oncologists and pharmacists. .

Unlock the power of comprehensive analytics, tailored EHR consulting, and expert insights to maximize access and drive impactful engagements. You’ll find the tools and expertise needed for informed decision-making and strategic growth.

Navigator365 Matrix is the only DOL-centric data platform that delivers AI-powered, real-time insights on HCP influencers’ digital activity, so you can amplify the most effective clinical & brand messages by activating the right DOLs through high-impact channels.